cancer drugs
ICR calls for faster access to innovative cancer drugs
April 25, 2019Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, R&D, access, cancer drugs, incentives, innovation, oncology, pricing
The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK. The call …
Edinburgh researchers genetically modify chickens to produce medicine filled eggs
January 29, 2019Manufacturing and Production Edinburgh, cancer drugs, medicines, monoclonal antibodies, proteins
Researchers at the University of Edinburgh have genetically modified chickens, meaning that they lay eggs containing human proteins which can …
Global oncology market to reach $150 billion by 2020, says IMS Health
June 2, 2016Research and Development IMS Health, annual global growth, cancer drugs, oncology
Global sales of oncology drugs rose to $107 billion in 2015, according to a new IMS Health report, with growth …
Merck’s colorectal cancer drug meets primary endpoint in Phase III study
April 25, 2016Research and Development, Sales and Marketing Erbitux, Merck, Serono, cancer drugs, colorectal cancer, increased survival, oncology, phase 3, phase III
Merck (FWB: MRK) has announced that its Phase III clinical trial of Erbitux, in combination with Folfox, met its primary …
TREND: Rare disease, cancer drugs will drive pharma M&A’s, growth
March 29, 2016Manufacturing and Production, Research and Development, Sales and Marketing M&A, MA, Orphan Drugs, cancer drugs
Moody’s Investor Service lowered its growth outlook for the global pharma sector but maintained the mergers and acquisitions in the …
EMA completes review of Ben Venue-made drugs
March 19, 2012Manufacturing and Production Ben Venue, EMA, cancer drugs, production
The European Medicines Agency has recommended that manufacturing of two cancer medicines be transferred from Ben Venue Laboratories plant in …
BMS skin cancer vaccine hits phase III target
March 23, 2011Research and Development BMS, Bristol-Myers Squibb, advanced inoperable skin cancer, advanced melanoma, cancer drugs, cancer vaccine, ipilimumab
Bristol Myers Squibb’s cancer vaccine ipilimumab has increased overall survival in advanced melanoma patients. The therapy was being tested as …
Sanofi prostate cancer drug Jevtana approved in Europe
March 21, 2011Sales and Marketing Jevtana, Sanofi-Aventis, TROPIC clinical trial, cabazitaxel, cancer drugs, chemotherapy, prostate cancer
Sanofi-Aventis’ new chemotherapy treatment Jevtana has followed up on its US approval last year by receiving the green light in …
NICE refuses cancer drugs Arzerra, Torisel and Levact
October 27, 2010Sales and Marketing Arzerra, GSK, NICE, Napp Pharmaceuticals, Pfizer, Torisel, Treanda, cancer drugs
NICE has refused to recommend a trio of cancer drugs for NHS use – but in two cases says this …
£600m confirmed for three year Cancer Drugs Fund
October 27, 2010Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NICE, cancer drugs, value-based pricing
The NHS will get the extra money it was promised to improve patient access to cancer medicines not backed by …
Latest content
FibroFind appoints Lee Borthwick as CEO
